House Subcommittee Considers FY25 Appropriations Bill with Increase in Cancer Research Funding

June 27, 2024

WASHINGTON, D.C. – Today, the House Appropriations Subcommittee on Labor Health and Human Services considered and approved its draft FY25 appropriations bill that includes increases for federal cancer research funding at the National Cancer Institute (NCI).

The House spending bill includes: $48.581 billion for the National Institutes of Health (NIH), which is the same as FY24 funding, including $7.875 billion for the National Cancer Institute (NCI), which is an increase of $651.1 million, and $500 million for the Advanced Research Projects Agency for Health (ARPA-H), which is a $1 billion cut from FY24 levels.

In response, Dr. Karen E. Knudsen, CEO of the American Cancer Society and the American Cancer Society Cancer Action Network released the following statement: 

“We are grateful to see a substantial increase in funding for NCI. There is a clear relationship between meaningful investment in cancer research and reduced mortality rates in the United States, dropping year over year since 1991. This increase will help bring us closer to our goal of ending cancer as we know it, for everyone.

“At the same time, we encourage the House Appropriations Committee to work in a bipartisan way to protect the nation’s foundational research investments at NIH, provide at least level funding for ARPA-H, and ensure increases for cancer prevention and screening programs at the Centers for Disease Control. With more than 2 million Americans expected to be diagnosed with cancer in 2024, sustained increased investments are critical to advancing the cancer treatments and cures of the future.”